# Break-through Infection Following Mpox vaccinatIon

> **NCT05522296** · — · COMPLETED · sponsor: **Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia** · enrollment: 3125 (actual)

## Conditions studied

- Mpox

## Interventions

- **DRUG:** Mpox Vaccine

## Key facts

- **NCT ID:** NCT05522296
- **Lead sponsor:** Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2022-09-12
- **Primary completion:** 2024-03-30
- **Final completion:** 2024-03-30
- **Target enrollment:** 3125 (ACTUAL)
- **Last updated:** 2024-06-06

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05522296

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05522296, "Break-through Infection Following Mpox vaccinatIon". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT05522296. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*